AFPAFT PHARMACEUTICALS LIMITED

Announcement history available from 1 August 2025

Fromto
Date / TimeTitleTypeMSReport Codes
31 July 2026, 23:19Results of MeetingMeetings & Governance08003
31 July 2026, 17:30AFT Chair David Flacks to retire before the next ASMOther12017
31 July 2026, 17:30Annual Meeting Presentation 2026Presentations03026, 15001
31 July 2026, 17:30Chair's Address to ShareholdersLetters & Addresses15002
28 July 2026, 17:30AFT R&D portfolio offers multi-$bn dollar market potentialPresentations03026
28 July 2026, 17:30AFT R&D portfolio offers multi-$bn market potentialCompany Update11001, 12008
24 July 2026, 17:54Pitt St Research initiates coverage on AFT PharmaceuticalsCompany Administration12008
21 July 2026, 19:00Scomara Tentative Approval by US FDACompany Update11001
7 July 2026, 17:30AFT reports ongoing sales growth and R&D progressCompany Update03014, 11001
3 July 2026, 01:17Notice of Annual Meeting of Shareholders 2026Meetings & Governance08001, 08004
24 June 2026, 23:54Update - Dividend/Distribution - AFPDividends & Distributions10001, 10002, 10003
24 June 2026, 17:31FDA allows AFT injectable iron project clinical studyCompany Administration12008
24 June 2026, 17:31FDA allows AFT injectable iron project clinical studyPresentations03026
22 June 2026, 18:13Application for quotation of securities - AFPOther06020
22 June 2026, 17:57Capital Change NoticeSecurities Administration06009
26 May 2026, 17:33Update - Dividend/Distribution - AFPDividends & Distributions10001, 10002, 10003
25 May 2026, 17:32Annual Meeting and Closing Date for Director NominationsMeetings & Governance08006
22 May 2026, 23:16Dividend/Distribution - AFPDividends & Distributions10001, 10002, 10003
22 May 2026, 18:30Issue of unlisted optionsSecurities Administration06009
21 May 2026, 20:07Dividend distribution updateDividends & DistributionsMS10001, 10002, 10003, 10006
21 May 2026, 17:31FY26 NZX App2Financial ResultsMS03003, 10001, 10002, 10003
21 May 2026, 17:30FY26 Annual ReportFinancial ResultsMS03001, 03002, 03011, 03012, 03024
21 May 2026, 17:30FY26 results presentationFinancial ResultsMS03004, 03026
21 May 2026, 17:30FY26 resultsFinancial ResultsMS03003, 03021, 10003
18 May 2026, 17:30AFT Pharmaceuticals names Stuart Houliston CFOCompany Administration12008
12 May 2026, 17:30AFT to release FY26 resultsPresentations03027, 14014
7 Apr 2026, 17:30March Quarter FY 2026 Investor UpdatePeriodic Reports03014
24 Mar 2026, 21:47Chief Financial Officer updateCompany Administration12008
9 Mar 2026, 18:40Court of Appeal dismisses PBL Port Wine Stain profit claimCompany Administration12008
15 Jan 2026, 18:30December Quarter FY 2026 Investor UpdateCompany Update11001
20 Nov 2025, 18:31FY26 Interim presentationFinancial ResultsMS03004, 03026
20 Nov 2025, 18:31FY26 Interim ReportFinancial ResultsMS03009, 03015, 03019
20 Nov 2025, 18:31FY26 Interim releaseFinancial ResultsMS03004
19 Nov 2025, 18:32AFT CFO Malcolm Tubby to retire Simon Bosley CFO DesignateCompany Administration12008
24 Oct 2025, 19:11AFT to announce half year interim results Nov 20Presentations03027, 14014
25 Sept 2025, 17:31September Quarter FY2026 Investor UpdateCompany Update03014, 11001
2 Sept 2025, 01:18Disclosure of Directors and Senior Managers Relevant InteresSubstantial Holders02006
4 Aug 2025, 22:44Results of 2025 Annual Shareholder MeetingMeetings & Governance08003
1 Aug 2025, 17:30AFT ASM PresentationPresentations03026, 15002
1 Aug 2025, 17:30AFT ASM Chairs SpeechLetters & Addresses15002
1 Aug 2025, 17:30AFT ASM ReleaseCompany Update08006, 11001, 12008
1–41 of 41
1 / 1